Stay updated on NanoFlu Vaccine Safety & Immunogenicity Clinical Trial
Sign up to get notified when there's something new on the NanoFlu Vaccine Safety & Immunogenicity Clinical Trial page.

Latest updates to the NanoFlu Vaccine Safety & Immunogenicity Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check21 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check29 days agoNo Change Detected
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check64 days agoChange DetectedThe page has undergone significant content removal regarding a clinical trial for a recombinant influenza vaccine, including detailed descriptions of the study design, inclusion and exclusion criteria, and the investigational product. The revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference25%
- Check72 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to NanoFlu Vaccine Safety & Immunogenicity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NanoFlu Vaccine Safety & Immunogenicity Clinical Trial page.